3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
22
Prostatic Neoplasms
12
Lung Neoplasms
12
Colorectal Neoplasms
12
Neoplasms
9
Pancreatic Neoplasms
6
Lymphoma
6
Hematologic Neoplasms
6
Uterine Cervical Neoplasms
4
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
Neoplasm Metastasis
4
Melanoma
4
Hematopoietic and Lymphatic System Neoplasm
4
Urinary Bladder Neoplasms
3
Sarcoma
3
Papillomavirus Infections
3
Obesity-Related Malignant Neoplasm
3
Obesity
3
Motor Activity
3
Endometrial Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Carcinoma In Situ
3
Anatomic Stage I Breast Cancer AJCC v8
3
Testicular Neoplasms
2
Smoking Cessation
2
Skin Carcinoma
2
Rectal Neoplasms
2
Pain
2
Overweight
2
Interventions
Bupivacaine
4
Saline Solution
3
Ketamine
3
Transcutaneous Electric Nerve Stimulation
2
Ropivacaine
2
Radiofrequency Ablation
2
Magnesium Sulfate
2
Ketorolac
2
Dexmedetomidine
2
Control Groups
2
Anesthesia, Local
2
Acupuncture Therapy
2
Acetaminophen
2
engage 8200
1
Yoga
1
Varenicline
1
Transdermal Patch
1
Therapeutics
1
Telemedicine
1
Surgical Instruments
1
STAMP-I protocol
1
Radiosurgery
1
Psilocybin
1
Palliative Care
1
Oxycodone
1
Music Therapy
1
Morphine
1
Methods
1
Levobupivacaine
1
Ketoprofen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Agnosia
×
Methods
×
1 year
×
Clear all
NCT07332377
2026-03-18
PsyMINT
Virginia Commonwealth University
Phase NA
Recruiting
25 enrolled